Skip to content

A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.

Randomized controlled trial · J Nutr · 2013. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 23303873

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.

Vulevic J, Juric A, Tzortzis G et al.
J Nutr · 2013

PubMed ID
23303873
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.